{"a":[{"_":"Moderna's mRNA flu shot mFlusiva snags FDA nod after refusal-to-file imbroglio","$":{"href":"/pharma/modernas-mrna-flu-shot-mflusiva-snags-fda-nod-after-refusal-file-imbroglio","hreflang":"en"}}]}
RegulatoryapprovedmFlusivaPositive
AI Analysis
Summary
Moderna received FDA approval for mFlusiva, its mRNA-based influenza vaccine, following an earlier refusal-to-file decision. This regulatory clearance represents a significant milestone for the company's mRNA platform expansion beyond COVID-19.
Outcome Details
FDA approval for mRNA-based influenza vaccine
Importance:8/10
Sentiment:
0.85
FDA approvalmRNA vaccineinfluenzaModerna
Related Companies
Read the original article
Published by FiercePharma on August 5, 2026 11:21 PM